Key result
HIV-positive patients undergoing PCI face a ~17% MACE rate at two years.
Why the study?
Limited data are available regarding the prognosis of HIV-positive patients undergoing PCI, including outcomes related to different kinds of stents.
Meta-Analysis (n=1,243)
Yes
HIV-positive patients undergoing PCI experience high rates of in-hospital and long-term MACE, highlighting the need for tailored therapies and potentially the use of drug-eluting stents in this high-risk population.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Peyracchia et al. (2019) conducted a meta-analysis in HIV infection requiring percutaneous coronary intervention (n=1,243). Percutaneous coronary intervention (PCI) was evaluated on In-hospital and long-term major adverse cardiac events (MACE) [composite endpoint of all-cause death or myocardial infarction (MI)] (95% CI 11.9-22.3). HIV-positive patients undergoing percutaneous coronary intervention experienced a long-term MACE rate of 17.4% (95% CI 11.9-22.3) at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: